# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-096899
Filing Date
2025-04-25
Accepted
2025-04-25 16:19:43
Documents
21
Period of Report
2025-06-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d901958ddef14a.htm iXBRL | DEF 14A | 613755
6 | GRAPHIC | g901958dsp004.jpg | GRAPHIC | 139367
7 | GRAPHIC | g901958dsp005.jpg | GRAPHIC | 128264
8 | GRAPHIC | g901958g02k01.jpg | GRAPHIC | 30082
9 | GRAPHIC | g901958g02k02.jpg | GRAPHIC | 20413
10 | GRAPHIC | g901958g04a03.jpg | GRAPHIC | 168995
11 | GRAPHIC | g901958g04a04.jpg | GRAPHIC | 167422
| Complete submission text file | 0001193125-25-096899.txt |  | 2911499

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | aldx-20241231.xsd | EX-101.SCH | 3750
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | aldx-20241231_def.xml | EX-101.DEF | 2967
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | aldx-20241231_lab.xml | EX-101.LAB | 3242
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | aldx-20241231_pre.xml | EX-101.PRE | 2147
23 | EXTRACTED XBRL INSTANCE DOCUMENT | d901958ddef14a_htm.xml | XML | 237324

Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36332 | Film No.: 25874384
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)